Milestone Pharmaceuticals : Corporate Presentation -March 28, 2024 at 08:38 am EDT
Company Overview March 28, 2024 Forward Looking Statement The Presentation contains forward-looking statements within...
Stay updated with breaking news from Drug Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Overview March 28, 2024 Forward Looking Statement The Presentation contains forward-looking statements within...
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that...
In Vanda Pharmaceuticals, Inc. v. United States, No. 23-629C (Fed. Cl. 2024), 2024 WL 201890, the Court of Federal Claims (COFC) addressed whether government disclosure of a company's trade secrets...
Fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder remains on trackPALISADE-3 trial initiation anticipated in 1H 2024; PALISADE-4 trial initiation anticipated in 2H 2024SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stag...
President Ferdinand ''Bongbong'' Marcos Jr. has directed the Food and Drug Administration (FDA) to streamline the drug application and regulatory processes in the Philippines.